Akero Therapeutics, Inc. (AKRO)

Last Closing Price: 55.62 (2025-06-13)

Expense Ratio (Annual)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

Akero Therapeutics, Inc. (AKRO) Expense Ratio data is not available.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
--
$-252.06M
--
--
$285.42M
$-285.42M
$33.36M
$-252.06M
$-252.06M
$-252.06M
$-252.06M
$-252.06M
$-252.06M
$-285.42M
$-297.92M
67.14M
67.14M
$-3.75
$-3.75
Balance Sheet Financials
$770.38M
--
$55.51M
$825.89M
$39.75M
$35.49M
$36.02M
$75.77M
$750.11M
$750.11M
$750.11M
72.38M
Cash Flow Statement Financials
$-230.11M
$-109.71M
$445.85M
$234.21M
$340.24M
$106.03M
$29.70M
--
--
Fundamental Metrics & Ratios
19.38
--
--
0.05
0.05
--
--
--
--
--
--
$-230.11M
--
Expense Ratio
--
--
--
--
--
--
-33.60%
-33.60%
-30.52%
-32.08%
$10.36
$-3.43
$-3.43